Identification of annexin II as a novel secretory biomarker for breast cancer (Q34982525)

5 August 2017

title

Identification of annexin II as a novel secretory biomarker for breast cancer (English)

1 reference

5 August 2017

0 references

Dong-Young Noh

1 reference

5 August 2017

Aree Moon

1 reference

5 August 2017

You Rim Jeon

1 reference

5 August 2017

Sun Young Kim

1 reference

5 August 2017

Eun Jeong Lee

1 reference

5 August 2017

Yong Nyun Kim

1 reference

5 August 2017

So Yeon Park

1 reference

5 August 2017

publication date

24 September 2013

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

3145-3156

1 reference

5 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Oncoproteomics: current trends and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Proteomics-driven cancer biomarker discovery: looking to the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Proteomic portrait of human breast cancer progression identifies novel prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Breast tumor microenvironment: proteomics highlights the treatments targeting secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Development of secreted proteins as biotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Aberrant function of the Ras signal transduction pathway in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

The cancer secretome: a reservoir of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Single-step perfusion chromatography with a throughput potential for enhanced peptide detection by matrix-assisted laser desorption/ ionization-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Antiproliferative activities of Garcinia bracteata extract and its active ingredient, isobractatin, against human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

HER2 induces expression of leptin in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

A novel technique to specifically analyze the secretome of cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Regulation of actin dynamics by annexin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Brefeldin A: insights into the control of membrane traffic and organelle structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Active caspase-1 is a regulator of unconventional protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Cochlin induced TREK-1 co-expression and annexin A2 secretion: role in trabecular meshwork cell elongation and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Annexin A2 as a differential diagnostic marker of hepatocellular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300127

21 January 2018

Identifiers

DOI

10.1002/PMIC.201300127

1 reference

5 August 2017

1 reference